Ichiro Yasuda

Toyama, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 286 publications

Peritoneal mesothelioma showing a remarkable response to nivolumab plus ipilimumab in a patient with Lynch syndrome: A case report and literature review.

Peritoneal mesothelioma showing a remarkable response to nivolumab plus ipilimumab in a patient with Lynch syndrome: A case report and literature review.

Journal: Internal medicine (Tokyo, Japan)

Published: July 30, 2026

Naldemedine Initiation Timing after Oxycodone Start and Early Laxative Adjustment in Cancer Care: A Retrospective Cohort Study.

Naldemedine Initiation Timing after Oxycodone Start and Early Laxative Adjustment in Cancer Care: A Retrospective Cohort Study.

Journal: Palliative medicine reports

Published: June 30, 2026

Three-Week Monitoring After Anamorelin Initiation in Unresectable or Recurrent Pancreatic Cancer: Dietary Intake Category, Observed Body Weight, and Prognostic Nutritional Index.

Three-Week Monitoring After Anamorelin Initiation in Unresectable or Recurrent Pancreatic Cancer: Dietary Intake Category, Observed Body Weight, and Prognostic Nutritional Index.

Journal: Journal of palliative medicine

Published: June 04, 2026

Third-Line Treatment Timing After Second-Line Discontinuation in Advanced Pancreatic Cancer: A 30-Day Landmark Analysis.

Third-Line Treatment Timing After Second-Line Discontinuation in Advanced Pancreatic Cancer: A 30-Day Landmark Analysis.

Journal: Journal of gastrointestinal cancer

Published: May 04, 2026

Efficacy and Safety of Endoscopic Ultrasound-Guided Biliary Drainage in the Management of Malignant Hilar Biliary Obstruction: A Multicenter Retrospective Cohort Study.

Efficacy and Safety of Endoscopic Ultrasound-Guided Biliary Drainage in the Management of Malignant Hilar Biliary Obstruction: A Multicenter Retrospective Cohort Study.

Journal: DEN open

Published: April 30, 2026

Chemotherapy for Unresectable Pancreatic Cancer Complicated by Disseminated Intravascular Coagulation: A Retrospective Cohort Study.

Chemotherapy for Unresectable Pancreatic Cancer Complicated by Disseminated Intravascular Coagulation: A Retrospective Cohort Study.

Journal: Pancreas

Published: April 28, 2026

Three-month follow-up of high-dose intravenous iron monotherapy for cancer-related anemia in an ESA-free oncology setting: a real-world cohort study.

Three-month follow-up of high-dose intravenous iron monotherapy for cancer-related anemia in an ESA-free oncology setting: a real-world cohort study.

Journal: International journal of clinical oncology

Published: April 28, 2026

Current diagnosis and treatment for biliary cancer

Current diagnosis and treatment for biliary cancer

Journal: Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology

Published: April 12, 2026

Clinical trajectories from first-line chemotherapy to best supportive care in unresectable pancreatic cancer: a 10-year real-world retrospective study.

Clinical trajectories from first-line chemotherapy to best supportive care in unresectable pancreatic cancer: a 10-year real-world retrospective study.

Journal: Cancer treatment and research communications

Published: April 09, 2026

Clinical Statistics and Outcomes of Pancreatic Neoplasms in Japan: A Retrospective Cohort Study using the Japan Pancreatic Cancer Registry.

Clinical Statistics and Outcomes of Pancreatic Neoplasms in Japan: A Retrospective Cohort Study using the Japan Pancreatic Cancer Registry.

Journal: Pancreas

Published: March 16, 2026

A multicenter randomized controlled trial comparing 10-mm versus 14-mm metallic stents for distal biliary obstruction caused by unresectable pancreatic carcinoma.

A multicenter randomized controlled trial comparing 10-mm versus 14-mm metallic stents for distal biliary obstruction caused by unresectable pancreatic carcinoma.

Journal: Gastrointestinal endoscopy

Published: March 08, 2026

On-Demand Loco-Regional Treatment for Intrahepatic Lesions Improves Treatment Outcomes in Atezolizumab Plus Bevacizumab Therapy for Unresectable Hepatocellular Carcinoma.

On-Demand Loco-Regional Treatment for Intrahepatic Lesions Improves Treatment Outcomes in Atezolizumab Plus Bevacizumab Therapy for Unresectable Hepatocellular Carcinoma.

Journal: Cancers

Published: February 28, 2026

Showing 1-12 of 286

Last Updated: 09/26/2026